Sustainability, Genetic Modification, and Advice of Investors in Advanced Therapies with Dr Dusko Ilic

Today we are back with our first guest episode with KCL's top Professor in Stem Cells, Dr Dusko Illic, who happens to be my professor from Stem Cells & Regenerative Therapies: From Bench to Market masters program. In the episode, we will debunk some stem cells myths and dive deep into what you need to know about stem cells in our 'Stem Cells in Context' segment:

1. Is genetic modification in embryos ethical or not?
2. How important is regulation for the genetic modification future?
3. What is the importance of companies on accountability for misleading the predicted success of their stem cell-based products?
4. What are the challenges and the future of sustainability in the life sciences (including stem cells) industry?

Having a leg in the commercial sector, our professor's advice on investment in the stem cell industry is something you cannot miss. He specifically highlights what makes me most excited by the stem cell industry. In his words, "It will be as exciting as the discovery of antibiotics".

We also value the man behind the science with a series of 'Getting to know you' questions in the new segment.

1.